The Ministry of Health Advises: False Amoxicillin + Clavulanic Acid Products circulating in Haiti

Port of Spain, 27th October, 2019: The World Health Organisation (WHO) has issued a Medical Product Alert for two (2) confirmed falsified versions of amoxicillin + clavulanic acid products which are circulating in Haiti. These products are presented under the names “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav”.

Genuine Amoxicillin/clavulanic acid is a combination, penicillin-type antibiotic, which is used to treat a wide variety of infections caused by bacteria, including infections of the ears, lungs, sinus, skin, and urinary tract.

Although Trinidad and Tobago was not included in the WHO alert, out of an abundance of caution, the Ministry of Health seeks to increase public awareness of this occurrence in Haiti.

The Ministry of Health is thereby advising the public, if you are in possession of the specific products (listed hereunder) please do not use. The falsified products are in the oral suspension form.

Augmentin and Amoxicillin Clavulanate Potassium

Batch Number 35405327A,

Exp 10 2020

Stated Manufacturer: Novopharm Limited and TEVA Pharmaceuticals USA


Batch Number BSTU0039

Manufacturing date 06/2017

Exp 05/2020

Stated Manufacturer: MYLAN

If you have taken these falsified medical products, or if you suffer an adverse event due to the consumption of these falsified products, please seek immediate advice from a qualified health care professional.

The Ministry of Health has also alerted other Government Border agencies to increase vigilance at the Borders.

It should be noted that the stated manufacturers of the products, MYLAN and Novopharm Limited and TEVA Pharmaceuticals USA, have informed the WHO that they have not produced these falsified products.

Members of the public may contact the Office of the Drug Inspectorate at 625-6049 and 627-0046 or the Chemistry Food and Drugs Division at 623-5242 for further information.

glqxz9283 sfy39587stf02 mnesdcuix8
Error | Trinidad and Tobago Government News


The website encountered an unexpected error. Please try again later.